Nabriva Therapeutics plc Quarterly Current Ratio in % from Q3 2017 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nabriva Therapeutics plc quarterly Current Ratio history and growth rate from Q3 2017 to Q2 2023.
  • Nabriva Therapeutics plc Current Ratio for the quarter ending June 30, 2023 was 109 %, a 70.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 109 -262 -70.7% Jun 30, 2023
Q1 2023 162 -261 -61.7% Mar 31, 2023
Q4 2022 234 -196 -45.6% Dec 31, 2022
Q3 2022 311 -110 -26.1% Sep 30, 2022
Q2 2022 371 -53.7 -12.6% Jun 30, 2022
Q1 2022 424 -5.64 -1.31% Mar 31, 2022
Q4 2021 429 +25.1 +6.21% Dec 31, 2021
Q3 2021 421 -65.9 -13.5% Sep 30, 2021
Q2 2021 425 -85.9 -16.8% Jun 30, 2021
Q1 2021 429 -84.4 -16.4% Mar 31, 2021
Q4 2020 404 -158 -28% Dec 31, 2020
Q3 2020 487 -92.4 -16% Sep 30, 2020
Q2 2020 511 -104 -16.9% Jun 30, 2020
Q1 2020 514 -137 -21% Mar 31, 2020
Q4 2019 562 -163 -22.5% Dec 31, 2019
Q3 2019 579 -182 -23.9% Sep 30, 2019
Q2 2019 615 -141 -18.7% Jun 30, 2019
Q1 2019 650 +3.45 +0.53% Mar 31, 2019
Q4 2018 725 +161 +28.4% Dec 31, 2018
Q3 2018 761 +224 +41.7% Sep 30, 2018
Q2 2018 756 Jun 30, 2018
Q1 2018 647 Mar 31, 2018
Q4 2017 565 Dec 31, 2017
Q3 2017 537 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.